Thymosin Beta-4 (TB4)

Description

Thymosin Beta-4 (TB-500 / TB4) is a synthetic peptide derived from the naturally occurring 43–amino-acid protein Thymosin Beta-4, present in nearly all human and animal cells. It is recognized for its powerful healing, regenerative, and anti-inflammatory properties, making it widely studied in tissue repair, wound healing, and musculoskeletal recovery.

Mechanism of Action

• Actin Regulation: TB-500 modulates actin polymerization, which is critical for cell migration, wound closure, and tissue remodeling.

• Angiogenesis: Stimulates formation of new blood vessels, enhancing nutrient and oxygen delivery to damaged tissue.

• Inflammation Control: Modulates inflammatory cytokines, reducing tissue damage and promoting a favorable healing environment.

• Cell Migration & Repair: Promotes movement of endothelial, epithelial, and stem cells to injury sites, accelerating regeneration of muscles, ligaments, tendons, skin, and even cardiac tissue.

• VEGF Upregulation: Enhances vascular endothelial growth factor, supporting tissue perfusion and repair.

Dosage Guidelines (Research/Experimental Use)

• General Dose: 1–2 mg, 2–3 times per week; can be split across multiple days.

• Cycle Length: Varies based on health status and treatment response.

• Administration: Subcutaneous injection; gently mix solution after reconstitution to avoid particulates.

Important Notes

• Solution may appear viscous or slightly opaque after reconstitution; this is normal.

• Discard if particulate matter or discoloration occurs.

• Well-tolerated with minimal side effects; mild injection site irritation may occur.

Class

Endogenous actin-binding and regenerative peptide

Research Focus

• Musculoskeletal injury repair

• Wound healing and skin regeneration

• Anti-inflammatory therapy

• Cardiac and neural tissue regeneration